Apoptosis induced by one new podophyllotoxin glucoside in human carcinoma cells

Toxicology

Volumn 212, Issue 1, 2005, Pages 46-53

  Zhang, Qiu Ying ^a   Jiang, Min ^a   Zhao, Chang Qi ^a   Yu, Miao ^a   Zhang, Hui ^a   Ding, Yu Jia ^a   Zhai, Yong Gong ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glucoside; HeLa; p53; Podophyllotoxin

Indexed keywords

4 NORPICROPODOPHYLLOTOXIN 7' O BETA DEXTRO GLUCOPYRANOSIDE; DNA FRAGMENT; GLUCOPYRANOSIDE; PODOPHYLLOTOXIN DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DOSE RESPONSE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; PODOPHYLLUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHIZOME; SINOPODOPHYLLUM EMODI;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; HELA CELLS; HUMANS; PLANT EXTRACTS; PODOPHYLLOTOXIN; PODOPHYLLUM; RHIZOME;

SINOPODOPHYLLUM;

EID: 20444379261     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.04.006     Document Type: Article

References (19)

1. R.T. Allen, W.J. Hunter III, and D.K. Agrawal Morphological and biochemical characterization and analysis of apoptosis J. Pharmacol. Toxicol. Methods 37 1997 215 228
2. Atta-Ur-Rahman, M.A. Iqbal Choudhary, Habib-Ur-Rehman, and M.H. Kazmi Antifungal aryltetralin lignans from leaves of podophyllum hexandrum Phytochemistry 40 1995 427 431
3. S. Duvvuri, B. Renuka, G.S. Kumar, and D.S. Deevi 9-Deoxopodophyllotoxin derivatives as anti-cancer agents Bioorg. Med. Chem. Lett. 9 1999 2131 2134
4. A. Girnita, L. Girnata, F. del Prete, A. Bartolazzi, O. Larsson, and M. Axelson Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth Cancer Res. 64 2004 236 242
5. M. Gordaliza, J.M.M. del Corral, M.A. Castro, P.A. Garci'a-Garci'a, and A.S. Feliciano Cytotoxic cyclolignans related to Podophyllotoxin IL Farmaco 56 2001 297 304
6. K.R. Hande Etoposide: four decades of development of a topoisomerase II Eur. J. Cancer 34 1998 1514 1521
7. WAF1, pRb, Mdm-2 Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus Eur. J. Cancer 36 2000 249 256
8. T.F. Imbert Discovery of podophyllotoxins Biochimie 80 1998 207 222
9. I.W. Kaplan Codylomata acuminate New Orleans Med. Surg. J. 94 1942 388 390
10. W.D. Macrae, and G.H.N. Towers Biological activities of lignans Phytochemistry 23 1984 1207 1220
11. S. Noriaki, Alaa-eldin Salah-eldin, W. Hidemichi, I. Tomoo, I. Hoichi, M. Tetsuya, and F. Seiichiro Bax, Bcl-2, and p53 expression in endometrial cancer Gynecol. Oncol. 86 2002 288 296
12. J.A. Pietenpol, and Z.A. Stewart Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis Toxicology 181-182 2002 475 481
13. L, and Bax in locally advanced squamous cell carcinoma of the lung Lung Cancer 45 2004 181 188
14. H.F. Stahelin, and A. von Warburg The chemical and biological route from podophyllotoxin to etoposide: Ninth Cain Memorial Award Lecture Cancer Res. 51 1991 5 15
15. J.C. Umney Podophyllum emodi Pharm. J. Trans. 23 1892 207 210
16. S.P. Vasavada, A.C. Novick, and B.R.G. Williams p53, Bcl-2, and Bax expression in renal cell carcinoma Urology 51 1998 1057 1061
17. V. Wootipoom, N. Lekhyananda, T. Phungrassami, P. Boonyaphiphat, and P. Thongsuksai Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy Gynecol. Oncol. 94 2004 636 642
18. S.C. Yeung, G. Xu, J. Pan, M. Christgen, and A. Bamiagis Manumycin enchances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells Cancer Res. 60 2000 650 656
19. C. Zhao, J. Huang, N. Akito, and O. Yukio Two new podophyllotoxin glycosides from Sinopodophyllum emodi (Wall.) Ying Chem. Pharm. Bull. 49 2001 773 775